fda warning letters bpc 157 letter bpc-157 unapproved new drug FDA Issues Warning to Companies Selling Dietary The trend of unproven peptides
Description
Seek medical attention for persistent or severe symptoms
Depending on the outcome, the peptides may become eligible for compoundingbut they would still not be FDA-approved drugs and may vary in quality and potency
@?%]4-\
Administered in research settings, BPC-157 demonstrated systemic healing properties
